Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $7.1 million.

  • Rallybio's Operating Expenses fell 4228.06% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.9 million, marking a year-over-year decrease of 4485.11%. This contributed to the annual value of $61.1 million for FY2024, which is 2255.11% down from last year.
  • As of Q3 2025, Rallybio's Operating Expenses stood at $7.1 million, which was down 4228.06% from $10.3 million recorded in Q2 2025.
  • Over the past 5 years, Rallybio's Operating Expenses peaked at $21.1 million during Q4 2023, and registered a low of $7.1 million during Q3 2025.
  • For the 3-year period, Rallybio's Operating Expenses averaged around $15.2 million, with its median value being $17.3 million (2024).
  • Per our database at Business Quant, Rallybio's Operating Expenses skyrocketed by 769.02% in 2024 and then crashed by 5005.81% in 2025.
  • Quarter analysis of 3 years shows Rallybio's Operating Expenses stood at $21.1 million in 2023, then crashed by 44.84% to $11.6 million in 2024, then plummeted by 38.72% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q3 2025, $10.3 million for Q2 2025, and $9.9 million during Q1 2025.